Abdullah G Al-Sehemi

InstitutionKing Khalid University
AddressAbha
Saudi Arabia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 44 publications over 10 distinct years, with a maximum of 8 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Basha GM, Parulekar RS, Al-Sehemi AG, Pannipara M, Siddaiah V, Kumari S, Choudhari PB, Tamboli Y. Design and in silico investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 Mpro. J Biomol Struct Dyn. 2021 Jul 26; 1-16. PMID: 34308790.
      Citations:    Fields:    
    2. Zia M, Muhammad S, Bibi S, Abbasi SW, Al-Sehemi AG, Chaudhary AR, Bai FQ. Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies. Bioorg Med Chem Lett. 2021 07 01; 43:128079. PMID: 33940136.
      Citations: 2     Fields:    Translation:HumansCells
    3. Khan MT, Ali S, Khan AS, Muhammad N, Khalil F, Ishfaq M, Irfan M, Al-Sehemi AG, Muhammad S, Malik A, Khan TA, Wei DQ. SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan. ACS Omega. 2021 Mar 16; 6(10):6588-6599. PMID: 33748571.
      Citations: 4     
    4. Muhammad S, Hassan SH, Al-Sehemi AG, Shakir HA, Khan M, Irfan M, Iqbal J. Exploring the new potential antiviral constituents of Moringa oliefera for SARS-COV-2 pathogenesis: An in silico molecular docking and dynamic studies. Chem Phys Lett. 2021 Mar 16; 767:138379. PMID: 33518774.
      Citations: 2     
    5. Kumar R, Harilal S, Al-Sehemi AG, Mathew GE, Carradori S, Mathew B. The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic. Curr Med Chem. 2021; 28(15):2852-2886. PMID: 32614740.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    6. Kumar R, Harilal S, Al-Sehemi AG, Pannipara M, Behl T, Mathew GE, Mathew B. COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2. Curr Pharm Des. 2021; 27(9):1194-1201. PMID: 33213323.
      Citations: 3     Fields:    Translation:HumansAnimals
    7. Al-Sehemi AG, Olotu FA, Dev S, Pannipara M, Soliman ME, Soliman ME, Carradori S, Mathew B. Natural Products Database Screening for the Discovery of Naturally Occurring SARS-Cov-2 Spike Glycoprotein Blockers. ChemistrySelect. 2020 Nov 13; 5(42):13309-13317. PMID: 33363254.
      Citations: 2     
    8. Al-Sehemi AG, Pannipara M, Parulekar RS, Patil O, Choudhari PB, Bhatia MS, Zubaidha PK, Tamboli Y. Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis. J Biomol Struct Dyn. 2021 Sep; 39(15):5804-5818. PMID: 32643550.
      Citations: 3     Fields:    Translation:HumansCells